• Call us
  • General

    Founded in 2016, Locsense develops non-invasive sensors like the Artemis to monitor cell health, offering a cruelty-free alternative to animal testing. Its technology measures cell barrier strength, crucial for drug testing, disease research, and understanding body defenses. Locsense devices integrate seamlessly with existing workflows and advanced in-vitro platforms like organ-on-chip and microfluidic chips.

    Frequently Asked Questions

    Find the answers to questions that are regularly asked by visitors to our website.

    News

    Stay up to date with our latest developments

    Resources

    News
    Switch content
    Resources
    Lab Sydney scaled e1685517914533

    Lung models for accelerated drug discovery

    Major step forward in alternatives to animal models for lung cells! Read the latest impactful results on in-vitro lung-models for accelerated drug discovery from our collaborators in Sydney, published in Biomaterials Research. The developed in-vitro models enable therapeutics development for COPD as well as assessment of effects of pollution on lungs. Congratulations on the great…

    Read more
    Skin pathology resize

    European Society for Dermatological Research conference

    At the ESDR (European Society for Dermatological Research) conference in Amsterdam sept 2022, Noa van den Brink presented results on monitoring the barrier function of skin epithelial cells using electrical impedance spectroscopy. Read her conclusions below!

    Read more
    E010 Crop scaled

    Techmed event 2021

    photo by Eric Brinkhorst. We are looking back at an inspiring Techmed Event at the University of Twente. Locsense was part of a panel discussion, lead by Constantijn Van Oranje-Nassau, about the challenges of building and scaling a medtech company. He interviewed four ceo’s of medtech companies at Kennispark Twente about the challenges that medtech companies…

    Read more
    View all
    Lab Sydney res

    Advanced pathophysiology mimicking lungmodels for accelerated drug discovery

    Background Respiratory diseases are the 2nd leading cause of death globally. The current treatments for chronic lung diseases are only supportive. Very few new classes of therapeutics have been introduced for lung diseases in the last 40 years, due to the lack of reliable lung models that enable rapid, cost-effective, and high-throughput testing. To accelerate…

    Read more
    2024 06 11 skin cells SC res

    The aryl hydrocarbon receptor regulates epidermal differentiation through transient activation of TFAP2A

    The aryl hydrocarbon receptor (AHR) is an evolutionary conserved environmental sensor identified as indispensable regulator of epithelial homeostasis and barrier organ function. Molecular signaling cascade and target genes upon AHR activation and their contribution to cell and tissue function are however not fully understood. Multi-omics analyses using human skin keratinocytes revealed that, upon ligand activation,…

    Read more
    Shutterstock 2118109721 (1)

    Electrical impedance spectroscopy quantifies skin barrier function in organotypic in vitro epidermis models

    3 D human epidermal equivalents (HEEs) are a state‐of‐the‐art organotypic culture model in preclinical investigative dermatology and regulatory toxicology. Here, we investigated the utility of electrical impedance spectroscopy (EIS) for non–invasive measurement of HEE epidermal barrier function. Our setup comprised a custom–made lid fit with 12 electrode pairs aligned on the standard 24–transwell cell culture…

    Read more
    View all